ARCHIVES

Pazdur: Registration Trials Run By Groups Need Same Rigor As Industry Trials

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

DCT Board Okay Recompetitions, Delays Decision On Clonogenic Assays

June 24, 1983

FDA Delays Decision On Avastin Approval For Breast Cancer

September 24, 2010

Hopkins Begins Review Of All Studies After OHRP Lifts Research Suspension.

July 27, 2001

Managed Care Plans Seek Cost Efficacy, Not Research, Center Directors Warned

March 17, 1995

Concepts For Education Initiatives In Breast Ca Approved As RFA

July 9, 1993

Oncologists lose money administering drugs to Medicare patients, survey finds.

January 23, 2004